alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

News

What's happening in Alzheimer's care, research funding, and treatment — summarized simply, each item linked to the original reporting.

Find news

1 of 349 news items, newest first.

Free to read, “May need a subscription” and “Archived copy”: what they mean

Whether an article is free to read is a guess, not a test of your access. Each item is one of three:

  • No label: free to read (304 of 349). The publisher’s page marks it free, or the outlet publishes free to read: Medical Xpress, ScienceDaily, NIH (incl. NIA and PMC), Alzheimer's Association, Alzheimer's News Today, NPR, Alzheimer's Disease International, or a .gov site.
  • May need a subscription (11 of 349). The publisher’s own page marks the article as not free to read, or — when the page says nothing — the outlet sells subscriptions: The New York Times, STAT, Scientific American, The Washington Post, The Wall Street Journal, Financial Times, The Economist, Bloomberg, The Atlantic, The New Yorker, Wired, Los Angeles Times, The Boston Globe, The Times, The Telegraph, New Scientist, Endpoints News, Science. Each badge says which.
  • “Free to read? Not known” (34 of 349). The outlet is on neither list and its page said nothing. We do not call these paywalled.

Archived copy links go to a copy the Internet Archive (web.archive.org) saved, dated the day it was saved. We show one only where the Internet Archive reported a working saved copy when we checked; an archived copy of a subscription article sometimes shows only its opening. 265 of 349 items have one.

Quest Diagnostics Launches New AD-Detect Blood Test to Aid in Confirming Alzheimer's Disease

Quest Diagnostics Diagnosis

Quest Diagnostics launched a new AD-Detect Abeta42/40 and p-tau217 blood test nationwide (except New York), combining two biomarkers into a proprietary 'Likelihood Score' that showed about 89% positive/negative predictive values in studies presented at the 2025 AAN meeting.

Why it matters: Expands commercial, direct-to-clinician access to blood-based Alzheimer's biomarker testing through one of the largest U.S. lab networks, at lower cost than PET scans or spinal taps.

Free to read? Not known for this outlet.

Read at Quest Diagnostics → Archived copy (17 Apr 2026), Internet Archive

Follow new items in a feed reader: Atom feed.